Morpholine → 6-[[2-(Morpholin-4-yl)-1-phenyl-1H-benzimidazol-6-yl]oxy]Hexanoic Acid Methyl Ester

HRID 1070860Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1070860
[CH3:1][O:2][C:3](=[O:26])[CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][O:9][C:10]1[CH:11]=[CH:12][C:13]2[N:17]=[C:16](Cl)[N:15]([C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=3)[C:14]=2[CH:25]=1.[NH:27]1[CH2:32][CH2:31][O:30][CH2:29][CH2:28]1>>[CH3:1][O:2][C:3](=[O:26])[CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][O:9][C:10]1[CH:11]=[CH:12][C:13]2[N:17]=[C:16]([N:27]3[CH2:32][CH2:31][O:30][CH2:29][CH2:28]3)[N:15]([C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=3)[C:14]=2[CH:25]=1

Komponenten

3

Edukt 2

HCID 8083MorpholineHCID 694308016-[[2-chloro-1-phenyl-1H-benzimidazol-6-yl]oxy]hexanoic acid methyl ester

Produkt 1

HCID 102958696-[[2-(Morpholin-4-yl)-1-phenyl-1H-benzimidazol-6-yl]oxy]Hexanoic Acid Methyl Ester

Reaktionsbedingungen

Temperatur
120 °C

Versuchsvorschrift

657 mg of 6-[[2-chloro-1-phenyl-1H-benzimidazol-6-yl]oxy]hexanoic acid methyl ester was dissolved in 13 ml of morpholine, and the mixture was stirred for 6 hours at 120° C. It was concentrated by evaporation to a very large extent in a vacuum, mixed with water, extracted with ethyl acetate, the organic phase was dried on sodium sulfate and concentrated by evaporation in a vacuum. The residue was purified by column chromatography on silica gel. 271 mg was obtained.

Aufarbeitung

  1. concentrationIt was concentrated by evaporation to a very large extent in a vacuum
  2. additionmixed with water
  3. extractionextracted with ethyl acetate
  4. customthe organic phase was dried on sodium sulfate
  5. concentrationconcentrated by evaporation in a vacuum
  6. customThe residue was purified by column chromatography on silica gel
  7. custom271 mg was obtained

Quellen und Nachweise

ORD-Eintrag
ord-bd21946634964f84a5d9ac294c5fff28
Quelldatensatz
uspto-grants-2005_06
Patentnummer
US06903126B2

Notizen zur Reaktion

Wird geladen…